ZERO Prostate Cancer has announced a significant boost to community health by awarding $250,000 in Community Innovation Grants to five organizations across the U.S. These grants are aimed at enhancing early detection and expanding care access for prostate cancer, especially in underserved areas.
Supported by Bayer, these grants will fund initiatives that include screenings, educational programs, and patient navigation services. The goal is to address disparities in prostate cancer outcomes effectively.
This grant program strengthens care locally and nationally by collaborating with organizations that understand their communities. Funded initiatives will provide free screenings, culturally sensitive awareness campaigns, and better coordination among care providers.
The 2026 grant recipients are:
- The George Washington University, Washington, D.C.
- UNC Health Foundation, Chapel Hill, North Carolina
- Michigan Men’s Health Foundation, Rochester, Michigan
- Center for Change, Inc., Orlando, Florida
- Facing Our Risk of Cancer Empowered, Tampa, Florida
These organizations will tailor programs to meet local needs, informed by data and community experience. This approach is crucial as prostate cancer disproportionately affects certain populations. In fact, according to recent studies, Black men are 1.7 times more likely to be diagnosed with prostate cancer than white men, emphasizing the need for targeted outreach.
ZERO Prostate Cancer, founded in 1996, is dedicated to supporting individuals and families impacted by the disease. Their mission revolves around raising awareness and advocating for equitable access to treatment.
Key Quotes:
“Local organizations play a vital role in saving lives. These grants equip community leaders to break down barriers and support high-risk men effectively,” says Courtney Bugler, President and CEO of ZERO Prostate Cancer.
Nicole Dinello, VP of Prostate Marketing at Bayer, adds, “Community organizations are often the first—and most trusted—support systems for families navigating prostate cancer. By backing this grant program, Bayer helps deliver on-the-ground solutions that matter.”
As these initiatives roll out, they’ll not only help individuals but also educate communities about the importance of early detection and proactive health measures. The potential impact is immense, setting a precedent for future health initiatives aimed at saving lives.
Source link
ZERO Prostate Cancer
